Dry Needling for Treating Spasticity in Multiple Sclerosis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-02-18

Study Completion Date

2020-09-22

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to evaluate the efficacy of dry needling (DN) in the treatment of spasticity in patients with multiple sclerosis (MS). \[Participants and Methods\] participants with MS, with no evidence of a relapse in the last four weeks and with an EDSS (Expanded Disability Sta- tus Scale) greater than 2.5 points (related with pyramidal score) were recruited. DN was performed in lower limbs for 12 consecutive sessions and evaluated with: EDSS (Pyramidal item), Time up and go (TUG), 25 foot, 9hold peg test (9HPT) and the improvement or not in the quality of life (MSQol54) was verified before and after treatment. A follow up visit was carried out to assess improvement.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Ultrasound-Guided Percutaneous Neuromodulation in Spasticity

NCT05053984

Multiple Sclerosis

UNKNOWN NA

Dry Needling and Pain Education in the Treatment of Chronic Neck Pain

NCT03095365

Pain, Neck

COMPLETED NA

Dry Needling in Multiple Sclerosis

NCT06394310

Multiple Sclerosis Spasticity

RECRUITING NA

Blinding and Previous Experiences of Dry Needling

NCT03592095

Neck Pain

COMPLETED NA

Clinical Outcomes After Dry Needling on Cervical Muscles, and Quality of Life, in Patients With Fibromyalgia Syndrome.

NCT03015662

Fibromyalgia

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Multiple Sclerosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

dry needling

This study has only 1 arm and the control group is their baseline data

Group Type EXPERIMENTAL

Dry needling

Intervention Type PROCEDURE

Only dry needling of the lower limbs will performed in all patients with acupunture needling

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dry needling

Only dry needling of the lower limbs will performed in all patients with acupunture needling

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Being a patient diagnosed with multiple sclerosis.
* Being over 18 years of age and less than or equal to 60 years of age.
* Having a score equal to or greater than 2 in the EDSS.
* They need to have a measurement in the following functional systems: P (pyramidal) \>2, CT (brainstem), gait \>2 and sphincter \>2.
* They need to present hypertonia or contractures of the muscles selected for the dry needling, the pain expressed by the patients must be a consequence of spastic processes, have hourly availability to receive therapies and not have needle phobias.

Exclusion Criteria

* Having a disease associated with multiple sclerosis that is incompatible with dry needling.
* Being in relapse, or having suffered it in the thirty days prior to starting the treatment. program or taking medications that are contraindicated with the technique applied in the study, (oral anticoagulants.)

Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes